Originally targeted at helping consumers identify foods that fit their genetic profiles, the kit was quickly retooled by Toumazou last year for use in point-of-care Covid testing. “We’re trying to bring medical-grade testing technology to the consumer.”DNANudge allows doctors, nurses or other medical personnel to test saliva for small pieces of DNA that contain key information about people or pathogens. DNANudge is only Ventura’s second medical technology investment, managing partner Mo El Husseiny said in an interview. “This is what I got back,” said El Husseiny, displaying his mobile phone screen on a Zoom interview. My house has become a sugar-free zone, much to my daughters’ consternation.”Now El Husseiny said he’s becoming very involved in DNANudge.

Source: The Edge Markets August 18, 2021 23:15 UTC